| PDF (706kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-268490
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.26849
Zusammenfassung
Biochemical and pharmacological investigations about the effect of the antidepressant drug viloxazine (Vivalan) on catecholamine metabolism in rats led to the following results: Viloxazine exerts a dose and time dependent inhibition of monoamine oxidase activity of brain and liver mitochondrial fraction and tissue homogenates of hypothalamus, heart, liver, and adrenal glands, both in vitro and ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags